Enzyme-mediated Interactions
Enzyme-Mediated Interactions is a pharmacological phenomenon in which the modulation of antimicrobial drug metabolism or activity occurs through the induction, inhibition, or competition involving drug-metabolizing enzymes, particularly cytochrome P450 isoenzymes or phase II conjugating enzymes, thereby altering the pharmacokinetic or pharmacodynamic profile of the co-administered antimicrobial agents.
21
Publications
1K
Citations
101
Authors
38
Institutions
Publications per year
2017–2026
2
21
1–5 of 21
101
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 101
38
Kyowa Kirin (Japan)
Tokyo, Japan
1 h-index
7 publications
441 citations
Purdue University West Lafayette
West Lafayette, United States
1 h-index
1 publications
75 citations
Istituto di Ematologia di Bologna
Bologna, Italy
1 h-index
1 publications
15 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
1 h-index
5 publications
160 citations

Biochemical Society
London, United Kingdom
1 h-index
5 publications
185 citations
University of Michigan
Ann Arbor, United States
1 h-index
2 publications
96 citations
Technical University of Denmark
Kongens Lyngby, Denmark
1 h-index
3 publications
33 citations
Politecnico di Milano
Milan, Italy
1 h-index
4 publications
52 citations
1–8 of 38
3 publications · 272 citations
3
h-index
PNAS · 2 publications · 219 citations
2
h-index
2 publications · 34 citations
2
h-index
1 publications · 36 citations
1
h-index
1 publications · 32 citations
1
h-index
1–5